Integrated transcriptomic, phenotypic, and functional study reveals tissue‐specific immune properties of mesenchymal stromal cells

Clinical‐grade mesenchymal stromal cells (MSCs) can be expanded from bone marrow and adipose tissue to treat inflammatory diseases and degenerative disorders. However, the influence of their tissue of origin on their functional properties, including their immunosuppressive activity, remains unsolved. In this study, we produced paired bone marrow‐derived mesenchymal stromal cell (BM‐MSC) and adipose‐derived stromal cell (ASC) batches from 14 healthy donors. We then compared them using transcriptomic, phenotypic, and functional analyses and validated our results on purified native MSCs to infer which differences were really endowed by tissue of origin. Cultured MSCs segregated together owing to their tissue of origin based on their gene expression profile analyzed using differential expression and weighted gene coexpression network analysis. This translated into distinct immune‐related gene signatures, phenotypes, and functional cell interactions. Importantly, sorted native BM‐MSCs and ASCs essentially displayed the same distinctive patterns than their in vitro‐expanded counterparts. As a whole, ASCs exhibited an immune profile consistent with a stronger inhibition of immune response and a lower immunogenicity, supporting the use of adipose tissue as a valuable source for clinical applications.

[1]  Anders K. Haakonsson,et al.  Obesity-Associated Hypermetabolism and Accelerated Senescence of Bone Marrow Stromal Stem Cells Suggest a Potential Mechanism for Bone Fragility. , 2019, Cell reports.

[2]  J. Aran,et al.  Complement components as promoters of immunological tolerance in dendritic cells. , 2017, Seminars in cell & developmental biology.

[3]  S. Lee,et al.  Comparative study on metabolite level in tissue-specific human mesenchymal stem cells by an ultra-performance liquid chromatography quadrupole time of flight mass spectrometry. , 2018, Analytica chimica acta.

[4]  Juping Yuan,et al.  Insight into the development of obesity: functional alterations of adipose‐derived mesenchymal stem cells , 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[5]  C. Shao,et al.  Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases , 2018, Nature Reviews Nephrology.

[6]  J. Galipeau,et al.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. , 2018, Cell stem cell.

[7]  A. Xiang,et al.  Stanniocalcin-2 contributes to mesenchymal stromal cells attenuating murine contact hypersensitivity mainly via reducing CD8+ Tc1 cells , 2018, Cell Death & Disease.

[8]  G. Gibson,et al.  Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach. , 2018, Cell reports.

[9]  Yufang Shi,et al.  Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells , 2017, Cell Death & Differentiation.

[10]  S. Woo,et al.  RNA sequencing reveals a transcriptomic portrait of human mesenchymal stem cells from bone marrow, adipose tissue, and palatine tonsils , 2017, Scientific Reports.

[11]  Sean C Warren,et al.  A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts. , 2017, Cell reports.

[12]  H. Qian,et al.  CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation Potential , 2017, Stem cells.

[13]  K. Tarte,et al.  IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma. , 2017, Blood.

[14]  A. Varin,et al.  CD54-Mediated Interaction with Pro-inflammatory Macrophages Increases the Immunosuppressive Function of Human Mesenchymal Stromal Cells , 2017, Stem cell reports.

[15]  K. Tarte,et al.  Brief Report: Proteasomal Indoleamine 2,3‐Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade‐Mesenchymal Stromal Cells Undergoing Replicative Senescence , 2017, Stem cells.

[16]  C. Plass,et al.  Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer , 2017, Oncoimmunology.

[17]  K. Le Blanc,et al.  Mesenchymal Stromal Cell Secretion of Programmed Death‐1 Ligands Regulates T Cell Mediated Immunosuppression , 2016, Stem cells.

[18]  L. Álvarez-Vallina,et al.  Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity , 2016, Front. Immunol..

[19]  J. Vendrell,et al.  Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells , 2016, Stem cells.

[20]  R. Yañez,et al.  Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor. , 2016, Cytotherapy.

[21]  D. Hursh,et al.  In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoter. , 2016, Cytotherapy.

[22]  A. Kirk,et al.  Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T‐Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing , 2016, Stem cells.

[23]  S. Scheding,et al.  Isolation and characterization of primary bone marrow mesenchymal stromal cells , 2016, Annals of the New York Academy of Sciences.

[24]  M. Zenke,et al.  Epigenetic Classification of Human Mesenchymal Stromal Cells , 2016, Stem cell reports.

[25]  K. Bieback,et al.  Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells , 2015, Front. Immunol..

[26]  K. Tarte,et al.  Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas , 2015, Oncotarget.

[27]  I. Weissman,et al.  Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. , 2015, Blood.

[28]  B. Nilsson,et al.  Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties ? , 2022 .

[29]  T. Handel,et al.  TSG-6 Inhibits Neutrophil Migration via Direct Interaction with the Chemokine CXCL8 , 2014, The Journal of Immunology.

[30]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[31]  R. Puri,et al.  MSC-based product characterization for clinical trials: an FDA perspective. , 2014, Cell stem cell.

[32]  M. Grãos,et al.  Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells , 2013, Stem Cell Research & Therapy.

[33]  Joelle Dulong,et al.  Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. , 2013, Stem cells and development.

[34]  Karin Tarte,et al.  Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application , 2013, Stem Cell Research & Therapy.

[35]  W. Fibbe,et al.  Adipose Tissue‐Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow‐Derived Counterparts , 2013, Stem cells translational medicine.

[36]  E. Verwiel,et al.  The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells. , 2013, Stem cells and development.

[37]  J. Fung,et al.  The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. , 2013, Blood.

[38]  Jacques Galipeau,et al.  The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? , 2013, Cytotherapy.

[39]  F. Lin,et al.  Mesenchymal stem cells are injured by complement after their contact with serum. , 2012, Blood.

[40]  C. Ware,et al.  Lymphotoxin-β receptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. , 2012, Immunity.

[41]  B. Sander,et al.  Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  D. Mooney,et al.  Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks , 2012, Nature Immunology.

[43]  Jacques Galipeau,et al.  Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[45]  D. Prockop,et al.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.

[46]  L. Casteilla,et al.  Native human adipose stromal cells: localization, morphology and phenotype , 2011, International Journal of Obesity.

[47]  Karin Tarte,et al.  Good manufacturing practices production of mesenchymal stem/stromal cells. , 2011, Human gene therapy.

[48]  P. Bourin,et al.  A first approach for the production of human adipose tissue-derived stromal cells for therapeutic use. , 2011, Methods in molecular biology.

[49]  J. Veltman,et al.  Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. , 2010, Stem cells and development.

[50]  Pierre Tattevin,et al.  Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. , 2010, The Journal of infectious diseases.

[51]  Na Li,et al.  Tumor Necrosis Factor Receptor Superfamily Member 19 (TNFRSF19) Regulates Differentiation Fate of Human Mesenchymal (Stromal) Stem Cells through Canonical Wnt Signaling and C/EBP* , 2010, The Journal of Biological Chemistry.

[52]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.